AI assistant
TELA Bio, Inc. — Director's Dealing 2025
May 30, 2025
34422_dirs_2025-05-30_3ef82fb5-df41-450e-b471-f5f1572d3c5b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TELA Bio, Inc. (TELA)
CIK: 0001561921
Period of Report: 2025-05-28
Reporting Person: EVANS DOUGLAS G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-28 | Common Stock | A | 7950 | — | Acquired | 18470 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-05-28 | Stock Option (Right to Buy) | $1.39 | A | 11700 | Acquired | 2035-05-28 | Common Stock (11700) | Direct |
Footnotes
F1: These restricted stock units vest on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
F2: The option vests on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.